- Home
- FBMS vs MYGN Comparison
FBMS vs MYGN Comparison
Compare FBMS & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBMS
- MYGN
- Stock Information
- Founded
- FBMS 1995
- MYGN 1991
- Country
- FBMS United States
- MYGN United States
- Employees
- FBMS N/A
- MYGN N/A
- Industry
- FBMS Major Banks
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FBMS Finance
- MYGN Health Care
- Exchange
- FBMS Nasdaq
- MYGN Nasdaq
- Market Cap
- FBMS 1.1B
- MYGN 1.2B
- IPO Year
- FBMS N/A
- MYGN 1995
- Fundamental
- Price
- FBMS $38.31
- MYGN $13.05
- Analyst Decision
- FBMS Buy
- MYGN Hold
- Analyst Count
- FBMS 2
- MYGN 12
- Target Price
- FBMS $45.00
- MYGN $22.00
- AVG Volume (30 Days)
- FBMS 140.4K
- MYGN 1.1M
- Earning Date
- FBMS 01-28-2025
- MYGN 02-25-2025
- Dividend Yield
- FBMS 2.60%
- MYGN N/A
- EPS Growth
- FBMS 2.09
- MYGN N/A
- EPS
- FBMS 2.44
- MYGN N/A
- Revenue
- FBMS $280,241,000.00
- MYGN $823,600,000.00
- Revenue This Year
- FBMS N/A
- MYGN $13.73
- Revenue Next Year
- FBMS $5.26
- MYGN $4.34
- P/E Ratio
- FBMS $15.77
- MYGN N/A
- Revenue Growth
- FBMS N/A
- MYGN 12.15
- 52 Week Low
- FBMS $22.96
- MYGN $12.04
- 52 Week High
- FBMS $39.13
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- FBMS 65.55
- MYGN 41.47
- Support Level
- FBMS $37.10
- MYGN $12.22
- Resistance Level
- FBMS $38.76
- MYGN $13.10
- Average True Range (ATR)
- FBMS 0.82
- MYGN 0.73
- MACD
- FBMS 0.30
- MYGN 0.07
- Stochastic Oscillator
- FBMS 87.81
- MYGN 29.67
About FBMS First Bancshares Inc.
First Bancshares Inc operates as a bank holding company. It offers various products and services such as deposit, including checking accounts, savings accounts, and time deposits account for individuals, businesses, associations and organizations, and governmental authorities. It also provides commercial and personal loans, including secured and unsecured loans, consumer loans, and loans for business expansion and purchase of equipment and machinery, and residential mortgage loans. The bank renders services like financial and wealth management, online internet banking, voice response telephone inquiry, safe deposit boxes, traveler's checks, and mobile deposit, and others. It operates in the Commercial/Retail Bank, Mortgage Banking, and Holding company segments.
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.